Failure of Traditional Risk Factors to Adequately Predict Cardiovascular Events in Older Populations

Jarrod E Dalton1,2, Michael B Rothberg1,3, Neal V Dawson4,5

  • 1Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio.

Insights

Standard cardiovascular risk factors poorly predict atherosclerotic cardiovascular disease (ASCVD) events in adults over 65. New risk models are needed for effective primary prevention in older populations.

Area of Science:

  • Gerontology
  • Cardiology
  • Epidemiology

Background:

  • Accurate assessment of atherosclerotic cardiovascular disease (ASCVD) risk is crucial for primary prevention, especially in diverse older adult populations.
  • The performance of standard cardiovascular risk factors in adults aged 65 and older is not well understood.

Purpose of the Study:

  • To evaluate the effectiveness of the American College of Cardiology/American Heart Association Pooled Cohort Equations (PCE) risk model in older adults.
  • To assess the performance of underlying cardiovascular risk factors in predicting ASCVD events among individuals over 65 years.

Main Methods:

  • Retrospective cohort study using electronic medical records from a regional referral system.
  • Included 25,349 patients aged 65 years or older at baseline (2007-2010).
  • Evaluated traditional cardiovascular risk factors and major ASCVD events (myocardial infarction, stroke, cardiovascular death).

Main Results:

  • The PCE model showed poor discrimination across all age groups (concordance index 0.52-0.62).
  • PCE predictions were lower than internally estimated models, particularly for African Americans.
  • Traditional risk factors like blood pressure, total cholesterol, and diabetes showed weak or inverse associations with ASCVD in older age groups.

Conclusions:

  • Traditional clinical risk factors inadequately characterize ASCVD risk in contemporary Medicare-aged patients.
  • Some risk factors were not associated with ASCVD events in adults aged 85 and older.
  • Improved risk models are necessary for effective treatment decisions in the growing elderly population.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
805
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
150
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
180
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
196
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
617
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
150